Zynerba Pharmaceuticals (ZYNE) Operating Income US GAAP (year values)

2018 2019 2020 2021 2022   LTM ? CAGR 5 years ?
Operating Income, bln rub -40.4 -34.3 -52.1 -36.8 -35.3   -38.8  
Changes by years, y/y, % +23% -15% +52% -29% -4%     +1.4%

Zynerba Pharmaceuticals. Operating Income, bln rub

Created with Highcharts 6.0.6-0.6-0.6-5.7-5.7-12.5-12.5-23.2-23.2-32.8-32.8-40.4-40.4-34.3-34.3-52.1-52.1-36.8-36.8-35.3-35.3-38.8-38.82013201420152016201720182019202020212022LTM-60-50-40-30-20-100smart-lab.ru

Zynerba Pharmaceuticals. Operating Income, changes, %

Created with Highcharts 6.0.6793.3793.3121.1121.185.285.241.441.423.123.1-15.0-15.051.751.7-29.4-29.4-4.1-4.110.010.0201420152016201720182019202020212022LTM-20002004006008001000smart-lab.ru

Zynerba Pharmaceuticals. Operating Income, sum by quarters, bln rub

Created with Highcharts 6.0.6-1.4-1.4-5.4-5.4-6.7-6.7-8.2-8.2-8.0-8.0-11.4-11.4-10.2-10.2-8.8-8.8-8.7-8.7-4.0-4.0-6.0-6.0-8.5-8.5-8.0-8.0-1.9-1.9-9.2-9.2-10.2-10.2-8.5-8.5-1.6-1.6-6.3-6.3-8.4-8.4-12.0-12.0-11.5-11.5-21.8-21.8-9.8-9.8-9.2-9.2-11.1-11.1-1.5-1.5-4.2-4.2-7.7-7.7-12.4-12.4-9.5-9.5-10.8-10.8-7.9-7.9-8.9-8.9-10.5-10.54 quarter3 quarter2 quarter1 quarter2014201520162017201820192020202120222023-60-50-40-30-20-100smart-lab.ru

Zynerba Pharmaceuticals (ZYNE) Operating Income US GAAP (quarter values)

2022Q2 2022Q3 2022Q4 2023Q1 2023Q2   LTM ?
Operating Income, bln rub -9.17 -8.49 -8.69 -10.5 -11.1   -38.8
Changes by years, y/y, % -7% -17% -1% +18% +21%    
Changes by quarters, q/q, % +3% -7% +2% +21% +6%    

Zynerba Pharmaceuticals. Operating Income, bln rub

Created with Highcharts 6.0.6-1.4-1.4-1.5-1.5-1.6-1.6-4.0-4.0-5.4-5.4-4.2-4.2-6.3-6.3-6.0-6.0-6.7-6.7-7.7-7.7-8.4-8.4-8.5-8.5-8.2-8.2-12.4-12.4-12.0-12.0-8.0-8.0-8.0-8.0-9.5-9.5-11.5-11.5-1.9-1.9-11.4-11.4-10.8-10.8-21.8-21.8-9.2-9.2-10.2-10.2-7.9-7.9-9.8-9.8-10.2-10.2-8.8-8.8-8.9-8.9-9.2-9.2-8.5-8.5-8.7-8.7-10.5-10.5-11.1-11.12014Q42015Q12015Q22015Q32015Q42016Q12016Q22016Q32016Q42017Q12017Q22017Q32017Q42018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q32022Q42023Q12023Q2-25-20-15-10-50smart-lab.ru

Zynerba Pharmaceuticals. Operating Income, changes, y/y, %

Created with Highcharts 6.0.6285.7285.7184.2184.2286.2286.250.150.123.423.481.681.633.133.142.642.622.722.760.960.943.143.1-6.6-6.6-1.9-1.9-23.6-23.6-3.8-3.8-75.9-75.941.941.914.114.189.789.7379.3379.3-10.7-10.7-27.0-27.0-55.0-55.010.610.6-13.5-13.512.912.9-6.8-6.8-16.8-16.8-1.5-1.517.617.621.521.52015Q42016Q12016Q22016Q32016Q42017Q12017Q22017Q32017Q42018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q32022Q42023Q12023Q2-1000100200300400500smart-lab.ru

Zynerba Pharmaceuticals. Operating Income, changes, q/q, %

Created with Highcharts 6.0.66.36.39.09.0145.6145.635.635.6-21.7-21.748.148.1-4.6-4.611.511.515.215.28.68.62.22.2-4.0-4.051.151.1-3.4-3.4-33.3-33.30.80.817.717.721.621.6-83.3-83.3492.7492.7-5.4-5.4102.3102.3-57.7-57.710.410.4-22.6-22.624.824.83.83.8-13.7-13.71.01.03.03.0-7.4-7.42.32.320.620.66.46.42015Q12015Q22015Q32015Q42016Q12016Q22016Q32016Q42017Q12017Q22017Q32017Q42018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q32022Q42023Q12023Q2-200-1000100200300400500600smart-lab.ru